Publication: Physicochemical Properties of Lipoproteins Assessed by Nuclear Magnetic Resonance as a Predictor of Premature Cardiovascular Disease. PRESARV-SEA Study
dc.contributor.author | Fernández-Cidón, Bárbara | |
dc.contributor.author | Candás-Estébanez, Beatriz | |
dc.contributor.author | Gil-Serret, Miriam | |
dc.contributor.author | Amigó, Núria | |
dc.contributor.author | Corbella, Emili | |
dc.contributor.author | Rodríguez-Sánchez, M. Ángeles | |
dc.contributor.author | Padró-Miquel, Ariadna | |
dc.contributor.author | Brotons, Carlos | |
dc.contributor.author | Hernández-Mijares, Antonio | |
dc.contributor.author | Calmarza, Pilar | |
dc.contributor.author | Jarauta, Estibaliz | |
dc.contributor.author | Brea, Angel J. | |
dc.contributor.author | Mauri, Marta | |
dc.contributor.author | Guijarro, Carlos | |
dc.contributor.author | Vila, Àlex | |
dc.contributor.author | Valdivielso, Pedro | |
dc.contributor.author | Corbella, Xavier | |
dc.contributor.author | Pintó, Xavier | |
dc.contributor.authoraffiliation | [Fernández-Cidón,B; Candás-Estébanez,B; Padró-Miquel,A] Bioquímica Especial y Biología Molecular, Laboratori Clínic, Hospital Universitario de Bellvitge, L’Hospitalet de Ll., Spain. [Candás-Estébanez,B] Clinical Laboratory, SCIAS-Hospital de Barcelona, Barcelona, Spain. [Gil-Serret,M; Amigó,N] Biosfer Teslab, Reus, Spain. [Amigó,N] CIBERDEM, Universidad Rovira i Virgili, Tarragona, Spain. [Corbella,E; Rodríguez-Sánchez,MA; Corbella,X; Pintó,X] Unidad de Lípidos y Riesgo Vascular, Servicio de Medicina Interna, Hospital Universitario de Bellvitge-IDIBELL, Barcelona, Spain. [Corbella,E; Pintó,X] Centro de Investigación Biomédica en Red, Fisiopatologia de la Obesidad y Nutrición CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain. [Brotons,C] EAP Sardenya, Instituto de Investigaciones Biomédicas Sant Pau, Barcelona, Spain. [Hernández-Mijares,A] Hospital Universitario Dr. Peset, Valencia, Spain. [Calmarza,P; Jarauta,E] Servicio de Bioquímica Clínica, Hospital Universitario Miguel Servet, CIBERCV IIS Aragón, Universidad de Zaragoza, Zaragoza, Spain. [Brea,AJ] Hospital General San Pedro, Logroño, Spain. [Mauri,M] Hospital de Terrassa (Consorci Sanitari de Terrassa), Terrassa, Spain. [Guijarro,C] Departamento de Esepecialidades Médicas y Salud Pública, Unidad de Medicina Interna, Hospital Universitario Fundación Alcorcón, Universidad Rey Juan Carlos, Alcorcón, Spain. [Vila,A] Hospital de Figueres (Fundació Salut Empordà), Figueres, Spain. [Valdivielso,P] Hospital Universitario Virgen de la Victoria, IBIMA, Universidad de Málaga, Málaga, Spain. [Corbella,X] Facultad de Medicina y Ciencias de la Salud, Universitat Internacional de Catalunya, Barcelona, Spain. [Pintó,X] Department of Medicine, Campus Bellvitge, Universidad de Barcelona, L’Hospitalet de Ll., Spain. | |
dc.contributor.funder | This work was supported in part by the Spanish Ministry of Health (Carlos III Health Institute) through the Fondo de Investigación para la Salud (FIS), which is co-funded by the European Regional Development Fund, funded by the following grant codes: PI16/01094 and PI19/01032. | |
dc.date.accessioned | 2023-01-16T11:53:00Z | |
dc.date.available | 2023-01-16T11:53:00Z | |
dc.date.issued | 2021-03-29 | |
dc.description.abstract | Some lipoprotein disorders related to the residual risk of premature cardiovascular disease (PCVD) are not detected by the conventional lipid profile. In this case-control study, the predictive power of PCVD of serum sdLDL-C, measured using a lipoprotein precipitation method, and of the physicochemical properties of serum lipoproteins, analyzed by nuclear magnetic resonance (NMR) techniques, were evaluated. We studied a group of patients with a first PCVD event (n = 125) and a group of control subjects (n = 190). Conventional lipid profile, the size and number of Very Low Density Lipoproteins (VLDL), Low Density Lipoproteins (LDL), High Density Lipoproteins (HDL) particles, and the number of particles of their subclasses (large, medium, and small) were measured. Compared to controls, PCVD patients had lower concentrations of all LDL particles, and smaller and larger diameter of LDL and HDL particles, respectively. PCVD patients also showed higher concentrations of small dense LDL-cholesterol (sdLDL), and triglycerides (Tg) in LDL and HDL particles (HDL-Tg), and higher concentrations of large VLDL particles. Multivariate logistic regression showed that sdLDL-C, HDL-Tg, and large concentrations of LDL particles were the most powerful predictors of PCVD. A strong relationship was observed between increased HDL-Tg concentrations and PCVD. This study demonstrates that beyond the conventional lipid profile, PCVD patients have other atherogenic lipoprotein alterations that are detected by magnetic resonance imaging (MRI) analysis. | es_ES |
dc.description.version | Yes | es_ES |
dc.identifier.citation | Fernández-Cidón B, Candás-Estébanez B, Gil-Serret M, Amigó N, Corbella E, Rodríguez-Sánchez MÁ, et al. Physicochemical Properties of Lipoproteins Assessed by Nuclear Magnetic Resonance as a Predictor of Premature Cardiovascular Disease. PRESARV-SEA Study. J Clin Med. 2021 Mar 29;10(7):1379 | es_ES |
dc.identifier.doi | 10.3390/jcm10071379 | es_ES |
dc.identifier.essn | 2077-0383 | |
dc.identifier.pmc | PMC8037702 | |
dc.identifier.pmid | 33805580 | es_ES |
dc.identifier.uri | http://hdl.handle.net/10668/4588 | |
dc.journal.title | Journal of Clinical Medicine | |
dc.language.iso | en | |
dc.page.number | 10 p. | |
dc.publisher | MDPI | es_ES |
dc.relation.publisherversion | https://www.mdpi.com/2077-0383/10/7/1379 | es_ES |
dc.rights | Atribución 4.0 Internacional | * |
dc.rights.accessRights | open access | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.subject | NMR analysis of lipoproteins | es_ES |
dc.subject | Lipid profile | es_ES |
dc.subject | Premature cardiovascular disease | es_ES |
dc.subject | Residual cardiovascular risk | es_ES |
dc.subject | Small dense LDL | es_ES |
dc.subject | Lipoprotein particle number | es_ES |
dc.subject | Lipoprotein precipitation | es_ES |
dc.subject | Triglycerides | es_ES |
dc.subject | Atherosclerosis | es_ES |
dc.subject | Lípidos | es_ES |
dc.subject | Enfermedades cardiovasculares | es_ES |
dc.subject | Factores de riesgo de enfermedad cardiaca | es_ES |
dc.subject | LDL-colesterol | es_ES |
dc.subject | Lipoproteínas | es_ES |
dc.subject | Triglycéridos | es_ES |
dc.subject | Aterosclerosis | es_ES |
dc.subject.mesh | Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans | es_ES |
dc.subject.mesh | Medical Subject Headings::Chemicals and Drugs::Lipids::Lipoproteins::Lipoproteins, LDL::Cholesterol, LDL | es_ES |
dc.subject.mesh | Medical Subject Headings::Diseases::Cardiovascular Diseases | es_ES |
dc.subject.mesh | Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Case-Control Studies | es_ES |
dc.subject.mesh | Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Models, Statistical::Logistic Models | es_ES |
dc.subject.mesh | Medical Subject Headings::Chemicals and Drugs::Lipids::Glycerides::Triglycerides | es_ES |
dc.subject.mesh | Medical Subject Headings::Chemicals and Drugs::Lipids::Lipoproteins | es_ES |
dc.subject.mesh | Medical Subject Headings::Chemicals and Drugs::Lipids::Lipoproteins::Lipoproteins, VLDL | es_ES |
dc.subject.mesh | Medical Subject Headings::Diseases::Cardiovascular Diseases::Vascular Diseases::Arterial Occlusive Diseases::Arteriosclerosis | es_ES |
dc.subject.mesh | Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Diagnostic Techniques and Procedures::Diagnostic Imaging::Magnetic Resonance Imaging | es_ES |
dc.title | Physicochemical Properties of Lipoproteins Assessed by Nuclear Magnetic Resonance as a Predictor of Premature Cardiovascular Disease. PRESARV-SEA Study | es_ES |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dspace.entity.type | Publication |
Files
Original bundle
1 - 2 of 2
Loading...
- Name:
- FernandezCidon_PhysicochemicalProperties.pdf
- Size:
- 459.1 KB
- Format:
- Adobe Portable Document Format
- Description:
- Artículo publicado
Loading...
- Name:
- FernandezCidon_PhysicochemicalProperties_MaterialSuplementario.pdf
- Size:
- 216.81 KB
- Format:
- Adobe Portable Document Format
- Description:
- Material suplementario